Diabetes Type 1
Conditions
Keywords
Diabetes type 1, Child ans teenager, Fear of Hypoglycaemia
Brief summary
Type 1 diabetes usually appears brutally in children or young adults. While many factors of poor glycemic balance have been identified in the literature (age, socio-cultural and socio-economic level, family structure, adherence etc.), it turns out that hypoglycemia is the most common acute complications. It would be an important physiological and psychological barrier for the patient and his parents to manage this diabetes, the latter seeking to keep the blood glucose levels above the objectives in order to avoid the occurrence of a hypoglycemia, especially nocturnal. If there is a questionnaire currently validated as a tool to measure the fear of hypoglycemia (HFS, Hypoglycemia Fear Survey is available in three versions: L'HFS-Child (HFS-C) for children over 6 years old, HFS-Parents of Young children ( HFS-PYC) for parents of young children (under 8 years of age) and HFS-Parents (HFS-P)) for parents of children over 8 years of age, on the other hand, there are no French and no French studies have evaluated the prevalence and impact of the fear of hypoglycemia in French patients with type 1 diabetes. It is therefore essential to use a reliable and valid tool to identify patients affected by the fear of hypoglycemia, which can be an obstacle to improve glycemic control and to an optimum quality of life. Having a tool in French and validated on the scientific level would allow to propose adapted therapeutic treatments (psychological follow-up, individual or collective sessions of therapeutic education, material assistance (sensor of blood glucose, pump with insulin stop...) In order to both improve metabolic balance while increasing the quality of life of patients by lowering secondary anxiety to hypoglycemia
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Age between 2 and 18 years * Type 1 diabetes defined by an hyperglycemia higher than 2g/l, polyuria, polydipsia and positive antibody * insulin-treated type 2 diabetes by daily injections or insulin pump
Exclusion criteria
* Trouble to read * Trouble to understand * Trouble to answer to the questionnaire * Opposition.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| HFS-Child score, | Month 0 | Change of Behaviour adopted by the patient in order to avoid the occurrence of hypoglycemia and worry about low blood sugar |
| HFS-PYC score | Month 0, Month 3 (+/- 30 days) | Change in Anxiety related to the phenomenon of hypoglycemia |
| HFS-Parent score | Month 0, Month 3 (+/- 30 days) | Change of Behaviour adopted by the parent in order to avoid the occurrence of hypoglycemia |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Questionnaire Survey "children " | Month 0, Month 3 (+/- 30 days) | Diabetes impact on relationships, activity, alimentation ... " children" |
| Questionnaire Survey "parents " | Month 0, Month 3 (+/- 30 days) | Diabetes impact on relationships, activity, alimentation ... " parents" |
| HbA1C | Month 0, Month 3 (+/- 30 days) | percentage value |
Countries
France